Why Your PCOS Treatment Isn't Working — A Doctor Explains
In a Nutshell
Standard PCOS care misses key drivers of androgen excess and insulin resistance. The most important fixes are resistance training plus HIIT, a 40:1 myo- to D-chiro-inositol ratio, 3–4 g daily omega-3, 30+ plant foods weekly for microbiome diversity, and strict evening blue-light control to protect melatonin. Stress reduction, morning light, and consistent sleep timing are also direct androgen-lowering interventions.
These notes were generated by AI and may contain inaccuracies.
If you have PMOS, what most people still know as PCOS, there's a good chance your management conversation went something like this. Eat better, exercise more, here's a prescription, and come back in 3 months. And if you followed that advice and still felt like something wasn't adding up, you're right. There's a lot the standard conversation leaves out. Today I'm going to cover seven of those gaps with the mechanism behind each one so you understand what to do and why it works. Stay until the end because the last one involves your evening light environment, and it's one of the simplest changes on this entire list with one of the most direct connections to the hormonal dysregulation driving PMOS. I'm Dr. Kabir Harichandan, a physician who's board certified in both family and obesity medicine, and before we get into it, here's a quick disclaimer. Even though I'm a doctor, I'm not your doctor. This is educational information only, not personal medical advice. Always discuss decisions about your health with your own physician first.
Your gut microbiome produces an enzyme called beta-glucuronidase, which breaks apart estrogen and androgens in the intestine, allowing them to be absorbed into circulation rather than letting them be excreted. In women with PMOS, research is now consistently showing a significantly altered gut microbiome with reduced microbial diversity and specific shifts in bacterial populations that increase beta-glucuronidase activity, promoting androgen recirculation. A landmark study published in the Journal of Clinical Endocrinology and Metabolism found that women with PMOS had measurably distinct gut microbiome profiles compared to controls, with specific reductions in Lactobacillus and Bifidobacterium species, and significant correlations between microbiome composition and androgen levels, markers of insulin resistance, and the severity of PMOS features. It also found that the gut microbiome isn't simply altered by PMOS, but may actively contribute to its perpetuation. A subsequent systemic review confirmed that probiotic supplementation, specifically strains targeting the microbiome disruption observed in PMOS, produce significant reduction in testosterone levels, fasting insulin, and inflammatory markers compared to placebo. So, these studies showed that supporting gut microbiome diversity may be a direct androgen and insulin management strategy in women with PMOS.
Sign in to read the full notes
Get access to AI-generated notes, topic timestamps, and more.